<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">ophthalmology</journal-id><journal-title-group><journal-title xml:lang="ru">Офтальмология</journal-title><trans-title-group xml:lang="en"><trans-title>Ophthalmology in Russia</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1816-5095</issn><issn pub-type="epub">2500-0845</issn><publisher><publisher-name>Ophthalmology</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.18008/1816-5095-2024-4-695-701</article-id><article-id custom-type="elpub" pub-id-type="custom">ophthalmology-2492</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОФТАЛЬМОХИРУРГИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>OPHTHALMOSURGERY</subject></subj-group></article-categories><title-group><article-title>Исследование влияния различных методов интраоперационной кератопротекции при факоэмульсификации возрастной катаракты на морфофункциональное состояние структур глазной поверхности в отдаленном послеоперационном периоде</article-title><trans-title-group xml:lang="en"><trans-title>Study of Influence of Various Methods of Intraoperative Keratoprotection in Phacoemulsification of Senile Cataract on Morphological and Functional State of Ocular Surface Structures in Late Postoperative Period</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6514-7236</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Тонконогий</surname><given-names>С. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Tonkonogiy</surname><given-names>S. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Тонконогий Сергей Викторович, врач‑офтальмолог 1‑го офтальмологического отделения</p><p>ул. Тихоокеанская, 211, Хабаровск, 680033</p></bio><bio xml:lang="en"><p>Tonkonogii Sergei V., ophthalmologist of the 1st Ophthalmological Department</p><p>Tikhookeanskaya str., 211, Khabarovsk, 680033</p></bio><email xlink:type="simple">naukakhvmntk@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7501-5571</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Коленко</surname><given-names>О. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Kolenko</surname><given-names>О. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Коленко Олег Владимирович, доктор медицинских наук, директор филиала; заведующий кафедрой офтальмологии Института повышения квалификации; профессор кафедры общей и клинической хирургии медицинского университета</p><p>ул. Тихоокеанская, 211, Хабаровск, 680033, </p><p>ул. Краснодарская, 9, Хабаровск, 680000, </p><p>ул. Муравьева‑Амурского, 35, Хабаровск, 680000</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9712-0276</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Васильев</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Vasiliev</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Васильев Алексей Владимирович, кандидат медицинских наук, заведующий 1‑м офтальмологическим отделением, врач‑офтальмолог</p><p>ул. Тихоокеанская, 211, Хабаровск, 680033</p></bio><bio xml:lang="en"><p>Vasiliev Alexey V., PhD, Chief of the 1st Ophthalmological Department, Ophthalmologist</p><p>Tikhookeanskaya str., 211, Khabarovsk, 680033</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Хабаровский филиал ФГАУ НМИЦ «МНТК “Микрохирургия глаза” им. академика С.Н. Федорова» Министерства здравоохранения Российской Федерации</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Khabarovsk Branch of the S. Fyodorov Eye Microsurgery Federal State Institution</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Хабаровский филиал ФГАУ НМИЦ «МНТК “Микрохирургия глаза” им. академика С.Н. Федорова» Министерства здравоохранения Российской Федерации;&#13;
КГБОУ ДПО «Институт повышения квалификации специалистов здравоохранения» Министерства здравоохранения Хабаровского края;&#13;
ФГБОУ ВО «Дальневосточный государственный медицинский университет» Министерства здравоохранения Российской Федерации</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Khabarovsk Branch of the S. Fyodorov Eye Microsurgery Federal State Institution; &#13;
Postgraduate Institute for Public Health Workers;&#13;
Far Eastern State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2024</year></pub-date><pub-date pub-type="epub"><day>23</day><month>12</month><year>2024</year></pub-date><volume>21</volume><issue>4</issue><fpage>695</fpage><lpage>701</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Тонконогий С.В., Коленко О.В., Васильев А.В., 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="ru">Тонконогий С.В., Коленко О.В., Васильев А.В.</copyright-holder><copyright-holder xml:lang="en">Tonkonogiy S.V., Kolenko О.V., Vasiliev A.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.ophthalmojournal.com/opht/article/view/2492">https://www.ophthalmojournal.com/opht/article/view/2492</self-uri><abstract><p>Цель — изучить влияние различных методов интраоперационной кератопротекции при факоэмульсификации возрастной катаракты (ФЭ ВК) на морфофункциональное состояние структур глазной поверхности (СГП) в отдаленном послеоперационном периоде.</p><sec><title> Пациенты и методы</title><p> Пациенты и методы. 240 пациентов (240 глаз), обратившихся для оперативного лечения возрастной катаракты. Средний возраст 65 ± 4 года, 109 мужчин, 131 женщина. Все больные по методу интраоперационной кератопротекции были разделены на три группы наблюдения. 1-я группа — 60 пациентов — орошение роговицы сбалансированным раствором. 2-я группа — 60 больных — на роговицу накладывали вискоэластик. 3-я группа: 3а подгруппа — 60 больных — на роговицу накладывали мягкую контактную линзу (МКЛ); 3б подгруппа — 60 пациентов — на роговицу накладывали МКЛ, пропитанную раствором рибофлавина. Кроме стандартного офтальмологического обследования проводили тест Ширмера-I, ОКТ-сканирование, определяли время разрыва слезной пленки (ВРСП).</p></sec><sec><title>Результаты</title><p>Результаты. Через один месяц после операции в 1-й группе выявлен наименьший показатель пробы Ширмера. Через 2 месяца после операции показатели не изменились. В финальном сроке наблюдения значимых межгрупповых отличий не отмечалось. Показатель ВРСП во всех группах уменьшился. Через 3 месяца после операции в глазах 3б подгруппы ВРСП оказалось значимо выше в сравнении с другими группами. Наилучшее состояние толщины эпителия роговицы (ТЭР) имело место в подгруппах 3а и 3б. При анализе эпителия по данным ОКТ-картирования роговицы отмечалось, что максимальное снижение ТЭР и количество дефектов было выявлено в 1-й и 2-й группах, а минимальное — в 3а и 3б подгруппе после операции. Предоперационные показатели осмолярности слезы не имели значимых межгрупповых различий. Через 3 месяца после операции показатели осмолярности слезы у пациентов 3а и 3б подгрупп были значительно ниже, чем у пациентов 1-й и 2-й групп. Показатели OSDI (Ocular Surface Disease Index) во всех группах перед операцией были сопоставимы. Через 3 месяца после операции минимальные значения OSDI были в 3а и 3б подгруппах. Ятрогенный синдром «сухого глаза» (ССГ) у пациентов 3б подгруппы был значительно ниже, чем у пациентов других групп.</p></sec><sec><title>Заключение</title><p>Заключение. Во всех исследуемых группах выявлена стандартная послеоперационная динамика СГП и ВРСП и изменения ТЭР с наименьшей вариативностью в 3б подгруппе. Наибольшую кератопротективную эффективность при ФЭ ВК показало применение МКЛ, пропитанной рибофлавином, поскольку позволило статистически значимо в сравнении с другими методами уменьшить частоту развития ССГ у пациентов после ФЭ ВК (р &lt; 0,05). Разработанный метод прогнозирования ятрогенного ССГ у пациентов после ФЭ ВК обладает высокой информативностью, поскольку количество пациентов 1-й группы с наличием ССГ соответствовало ожидаемому в пределах допустимой погрешности.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Purpose</title><p>Purpose: to study the effect of various methods of intraoperative keratoprotection in phacoemulsification (PE) of senile cataract (SC) on morphological and functional state of the ocular surface structures (OSS) in the late postoperative period.</p></sec><sec><title>Patients and methods</title><p>Patients and methods. 240 patients (240 eyes) who applied for surgical treatment of SC. Age: 65 ± 4 years. 109 men, 131 women. All patients were divided into three observation groups according to the method of intraoperative keratoprotection: 1st group — 60 patients, corneal irrigation with balanced solution; 2nd group — 60 patients, ophthalmic viscosurgical device was applied to the cornea; 3rd group: 3a subgroup — 60 patients, soft contact lens (SCL) was applied to the cornea; subgroup 3b — 60 patients, SCL impregnated with riboflavin solution was applied to the cornea. In addition to the standard ophthalmological examination, Schirmer I test, OCT-scanning were performed, and tear breakup time (TBUT) was determined.</p></sec><sec><title>Results</title><p>Results. The lowest indicator of Schirmer I test was detected in the 1st group a month after the operation. The indicators did not change 2 months after the operation. There were no significant intergroup differences in the final observation period. The TBUT index in all groups decreased. 3 months after the operation, TBUT in the eyes of 3b subgroup was significantly higher in comparison to other groups. The best state of corneal epithelium thickness (CET) occurred in 3a and 3b subgroups. During the epithelium analysis according to OCT-mapping of the cornea, it was noted that the maximum decrease of CET and the number of defects was detected in the 1st and 2nd groups, and the minimum — in 3a and 3b subgroups at all follow-up periods after surgery. There were no significant intergroup differences in preoperative tear osmolarity. 3 months after surgery, tear osmolarity in patients of 3a and 3b subgroups was significantly lower than in patients of the 1st and 2nd groups. OSDI scores in all groups before surgery were comparable. 3 months after the operation, the minimum OSDI values were 3a and 3b in subgroups. Iatrogenic dry eye syndrome (DES) in patients of 3b subgroup was significantly lower than in patients of other groups.</p></sec><sec><title>Conclusion</title><p>Conclusion. In all the studied groups, the standard postoperative dynamics of OSS and TBUT and changes in CET were revealed, with the least variability in 3b subgroup. The use of SCL saturated with riboflavin showed the highest keratoprotective efficacy in PE SC, as it allowed a statistically significant reduction in the incidence of DES in patients after PE in SC (p &lt; 0.05) in comparison with other methods. The developed method for predicting iatrogenic DES in patients after PE in SC is highly informative, because the number of patients in the 1st group with DES was within the expected range of error.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>возрастная катаракта</kwd><kwd>слезопродукция</kwd><kwd>синдром сухого глаза</kwd><kwd>факоэмульсификация</kwd></kwd-group><kwd-group xml:lang="en"><kwd>senile cataract</kwd><kwd>tear production</kwd><kwd>dry eye syndrome</kwd><kwd>phacoemulsification</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Бржеский ВВ, Сомов ЕЕ. Роговичноконъюнктивальный ксероз (диагностика, клиника, лечение). СПб.: Издво «Левша. СанктПетербург», 2003.</mixed-citation><mixed-citation xml:lang="en">Brzhesky VV, Somov EE. Cornealconjunctival xerosis (diagnosis, clinic, treatment). St. Petersburg: Publishing house «Levsha. St. Petersburg», 2003 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Vision 2020: the cataract challenge. Community Eye Health. 2000;13(34):17–19.</mixed-citation><mixed-citation xml:lang="en">Vision 2020: the cataract challenge. Community Eye Health. 2000;13(34):17–19.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">GarciaCatalan MR, JerezOlivera E, BenitezDelCastilloSanchez JM. Dry eye and quality of life. Arch Soc Esp Oftalmol. 2009;84(9):451–458. doi: 10.4321/s0365-66912009000900004.</mixed-citation><mixed-citation xml:lang="en">GarciaCatalan MR, JerezOlivera E, BenitezDelCastilloSanchez JM. Dry eye and quality of life. Arch Soc Esp Oftalmol. 2009;84(9):451–458. doi: 10.4321/s0365-66912009000900004.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Na KS, Han K, Park YG, Na C, Joo CK.. Depression, stress, quality of life, and dry eye disease in Korean women: a populationbased study. Cornea. 2015;34(7):733– 738. doi: 10.1097/ico.0000000000000464.</mixed-citation><mixed-citation xml:lang="en">Na KS, Han K, Park YG, Na C, Joo CK.. Depression, stress, quality of life, and dry eye disease in Korean women: a populationbased study. Cornea. 2015;34(7):733– 738. doi: 10.1097/ico.0000000000000464.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Kasetsuwan N, Satitpitakul V, Changul T, Jariyakosol S. Incidence and pattern of dry eye after cataract surgery. PLoS One. 2013;8(11):e78657. doi: 10.1371/journal.pone.0078657.</mixed-citation><mixed-citation xml:lang="en">Kasetsuwan N, Satitpitakul V, Changul T, Jariyakosol S. Incidence and pattern of dry eye after cataract surgery. PLoS One. 2013;8(11):e78657. doi: 10.1371/journal.pone.0078657.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Jiang D, Xiao X, Fu T, Mashaghi A, Liu Q, Hong J. Transient tear film dysfunction after cataract surgery in diabetic patients. PLoS One. 2016;11(1):e0146752. doi: 10.1371/journal.pone.0146752.</mixed-citation><mixed-citation xml:lang="en">Jiang D, Xiao X, Fu T, Mashaghi A, Liu Q, Hong J. Transient tear film dysfunction after cataract surgery in diabetic patients. PLoS One. 2016;11(1):e0146752. doi: 10.1371/journal.pone.0146752.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Xue W, Zhu MM, Zhu BJ, Huang JN, Sun Q, Miao YY, Zou HD. Longterm impact of dry eye symptoms on visionrelated quality of life after phacoemulsification surgery. Int. Ophthalmol. 2019; 39(2):419–429. doi: 10.1007/s10792-018-0828-z.</mixed-citation><mixed-citation xml:lang="en">Xue W, Zhu MM, Zhu BJ, Huang JN, Sun Q, Miao YY, Zou HD. Longterm impact of dry eye symptoms on visionrelated quality of life after phacoemulsification surgery. Int. Ophthalmol. 2019; 39(2):419–429. doi: 10.1007/s10792-018-0828-z.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Willcox MDP, Argüeso P, Georgiev GA, Holopainen JM, Laurie GW, Millar TJ, Papas EB, Rolland JP, Schmidt TA, Stahl U, Suarez T, Subbaraman LN, Uçakhan OÖ, Jones L. TFOS DEWS II Tear Film Report. Ocul Surf. 2017;15(3):366–403. doi: 10.1016/j.jtos.2017.03.006.</mixed-citation><mixed-citation xml:lang="en">Willcox MDP, Argüeso P, Georgiev GA, Holopainen JM, Laurie GW, Millar TJ, Papas EB, Rolland JP, Schmidt TA, Stahl U, Suarez T, Subbaraman LN, Uçakhan OÖ, Jones L. TFOS DEWS II Tear Film Report. Ocul Surf. 2017;15(3):366–403. doi: 10.1016/j.jtos.2017.03.006.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Kohli P, Arya SK, Raj A, Handa U. Changes in ocular surface status after phacoemulsification in patients with senile cataract. Int Ophthalmol. 2019;39(6):1345– 1353. doi: 10.1007/s10792-018-0953-8.</mixed-citation><mixed-citation xml:lang="en">Kohli P, Arya SK, Raj A, Handa U. Changes in ocular surface status after phacoemulsification in patients with senile cataract. Int Ophthalmol. 2019;39(6):1345– 1353. doi: 10.1007/s10792-018-0953-8.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Sahu PK, Das GK, Malik A, Biakthangi L. Dry eye following phacoemulsification surgery and its relation to associated intraoperative risk factors. Middle East Afr J Ophthalmol. 2015;22(4):472–477. doi: 10.4103/0974-9233.151871.</mixed-citation><mixed-citation xml:lang="en">Sahu PK, Das GK, Malik A, Biakthangi L. Dry eye following phacoemulsification surgery and its relation to associated intraoperative risk factors. Middle East Afr J Ophthalmol. 2015;22(4):472–477. doi: 10.4103/0974-9233.151871.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Sajnani R, Raia S, Gibbons A, Chang V, Karp CL, Sarantopoulos CD, Levitt RC, Galor A. Epidemiology of persistent postsurgical pain manifesting as dry eyelike symptoms after cataract surgery. Cornea. 2018;37(12):1535–1541. doi: 10.1097/ICO.0000000000001741.</mixed-citation><mixed-citation xml:lang="en">Sajnani R, Raia S, Gibbons A, Chang V, Karp CL, Sarantopoulos CD, Levitt RC, Galor A. Epidemiology of persistent postsurgical pain manifesting as dry eyelike symptoms after cataract surgery. Cornea. 2018;37(12):1535–1541. doi: 10.1097/ICO.0000000000001741.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Бакшеева ВЕ, Ганчарова ОС, Тюлина ВВ, Иомдина ЕН, Замятнин АА мл., Филиппов ПП, Зерний ЕЮ, Сенин ИИ Ятрогенные повреждения тканей глаза: современное понимание проблемы и пути ее решения. Биохимия. 2019;84(1):38–52. doi: 10.1134/S0320972519010032.</mixed-citation><mixed-citation xml:lang="en">Baksheeva VE, Gancharova OS, Tiulina VV, Iomdina EN, ZamyatninJr AA, Philippov PP, Zernii EYu, Senin II. Iatrogenic damage of eye tissues: current problems and possible solutions. Biochemistry. 2019;84(1):38–52 (InRuss.). doi: 10.1134/S0320972519010032.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Mikalauskiene L, Grzybowski A, Zemaitiene R. Ocular surface changes associated with ophthalmic surgery. J Clin Med. 2021;10(8):1642. doi: 10.3390/jcm10081642.</mixed-citation><mixed-citation xml:lang="en">Mikalauskiene L, Grzybowski A, Zemaitiene R. Ocular surface changes associated with ophthalmic surgery. J Clin Med. 2021;10(8):1642. doi: 10.3390/jcm10081642.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Тонконогий СВ, Коленко ОВ, Васильев АВ, Пашенцев ЯЕ. Способ прогнозирования развития синдрома «сухого глаза» после факоэмульсификации возрастной катаракты. Патент RU 2728971, 03.18.2020.</mixed-citation><mixed-citation xml:lang="en">Tonkonogii SV, Kolenko OV, Vasil’ev AV, Pashentsev YaE. Method for predicting the development of the “dry eye” syndrome after phacoemulsification of agerelated cataract. Patent RU 2728971, 03.18.2020 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Тонконогий СВ, Васильев АВ. Способ интраоперационной кератопротекции при факоэмульсификации. Патент RU 697631, 19.08.2019.</mixed-citation><mixed-citation xml:lang="en">Тонконогий СВ, Васильев АВ. Способ интраоперационной кератопротекции при факоэмульсификации. Патент RU 697631, 19.08.2019. Tonkonogii SV, Vasil’ev AV. Method of intraoperative keratoprotection during phacoemulsification. Patent RU 2728971, 03.18.2020 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Hiroko BM. Cataract surgery in the presence of other ocular comorbidities. In: Steinert RF, eds, Cataract surgery: technique, complication and management. Saunders; 2004: chap. 32.</mixed-citation><mixed-citation xml:lang="en">Hiroko BM. Cataract surgery in the presence of other ocular comorbidities. In: Steinert RF, eds, Cataract surgery: technique, complication and management. Saunders; 2004: chap. 32.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Walker TD. Benzalkonium toxicity. Clin Exp Ophthalmol. 2004;32(6):657. doi: 10.1111/j.1442-9071.2004.00922.x.</mixed-citation><mixed-citation xml:lang="en">Walker TD. Benzalkonium toxicity. Clin Exp Ophthalmol. 2004;32(6):657. doi: 10.1111/j.1442-9071.2004.00922.x.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Seen S, Tong L. Dry eye disease and oxidative stress. ActaOphthalmol. 2018;96(4):e412– e420. doi: 10.1111/aos.13526.</mixed-citation><mixed-citation xml:lang="en">Seen S, Tong L. Dry eye disease and oxidative stress. ActaOphthalmol. 2018;96(4):e412– e420. doi: 10.1111/aos.13526.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Hsueh YJ, Chen YN, Tsao YT, Cheng CM, Wu WC, Chen HC. The pathomechanism, antioxidant biomarkers, and treatment of oxidative stressrelated eye diseases. Int J Mol Sci. 2022;23(3):1255. doi: 10.3390/ijms23031255.</mixed-citation><mixed-citation xml:lang="en">Hsueh YJ, Chen YN, Tsao YT, Cheng CM, Wu WC, Chen HC. The pathomechanism, antioxidant biomarkers, and treatment of oxidative stressrelated eye diseases. Int J Mol Sci. 2022;23(3):1255. doi: 10.3390/ijms23031255.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Augustin AJ, Dick HB. Oxidative tissue damage after phacoemulsification: influence of ophthalmic viscosurgical devices. J Cataract Refract Surg. 2004;30(2):424– 427. doi: 10.1016/S0886-3350(03)00577-7.</mixed-citation><mixed-citation xml:lang="en">Augustin AJ, Dick HB. Oxidative tissue damage after phacoemulsification: influence of ophthalmic viscosurgical devices. J Cataract Refract Surg. 2004;30(2):424– 427. doi: 10.1016/S0886-3350(03)00577-7.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Periman LM, Perez VL, Saban DR, Lin MC, Neri P. The immunological basis of dry eye disease and current topical treatment options. J Ocul Pharmacol Ther. 2020;36(3):137–146. doi: 10.1089/jop.2019.0060.</mixed-citation><mixed-citation xml:lang="en">Periman LM, Perez VL, Saban DR, Lin MC, Neri P. The immunological basis of dry eye disease and current topical treatment options. J Ocul Pharmacol Ther. 2020;36(3):137–146. doi: 10.1089/jop.2019.0060.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Barbosa FL, Xiao Y, Bian F, Coursey TG, Ko BY, Clevers H, de Paiva CS, Pflugfelder SC. Goblet cells contribute to ocular surface immune toleranceimplications for dry eye disease. Int J Mol Sci. 2017;18(5):978. doi: 10.3390/ijms18050978.</mixed-citation><mixed-citation xml:lang="en">Barbosa FL, Xiao Y, Bian F, Coursey TG, Ko BY, Clevers H, de Paiva CS, Pflugfelder SC. Goblet cells contribute to ocular surface immune toleranceimplications for dry eye disease. Int J Mol Sci. 2017;18(5):978. doi: 10.3390/ijms18050978.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Fan NW, Dohlman TH, Foulsham W, McSoley M, Singh RB, Chen Y, Dana R. The role ofTh17 immunity in chronic ocularsurface disorders. Ocul Surf. 2021;19:157–168. doi: 10.1016/j.jtos.2020.05.009.</mixed-citation><mixed-citation xml:lang="en">Fan NW, Dohlman TH, Foulsham W, McSoley M, Singh RB, Chen Y, Dana R. The role ofTh17 immunity in chronic ocularsurface disorders. Ocul Surf. 2021;19:157–168. doi: 10.1016/j.jtos.2020.05.009.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Patel V, Chivukula IV, Roy S, Khanna S, He G, Ojha N, MehrotraA, Dias LM, Hunt TK, Sen CK. Oxygen: from the benefits of inducing VEGF expression to managing the risk of hyperbaric stress. Antioxid Redox Signal. 2005;7(9–10):1377–1387. doi: 10.1089/ars.2005.7.1377.</mixed-citation><mixed-citation xml:lang="en">Patel V, Chivukula IV, Roy S, Khanna S, He G, Ojha N, MehrotraA, Dias LM, Hunt TK, Sen CK. Oxygen: from the benefits of inducing VEGF expression to managing the risk of hyperbaric stress. Antioxid Redox Signal. 2005;7(9–10):1377–1387. doi: 10.1089/ars.2005.7.1377.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
